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Abstract-Ascorbic acid deficiency causes qualitative and quantitative differences in the guinea pig 
hepatic flavin-containing monooxygenase (FMO). Kinetic studies with purified FM0 indicated no 
significant change in the apparent K,,, of dimethylaniline or NADPH in ascorbate-supplemented or 
-deficient animals. Following purification of ascorbate-deficient guinea pig FM0 by DEAE-cellulose and 
blue agarose chromatography, exogenous FAD was required for 15% of the FM0 microsomal activity 
recovered. In contrast, only 5% of the total microsomal enzyme recovered from ascorbate-supplemented 
animals required exogenous FAD. Furthermore, there was an enhanced sensitivity to time-dependent 
nonlinearity with the purified ascorbate-deficient guinea pig FMO. The degree of time-dependent 
nonlinearity was related to the concentration of substrate. Also, purified ascorbate-supplemented guinea 
pig FM0 was stable for 4 weeks at -2O”, whereas the ascorbate-deficient enzyme was inactivated. A 
decrease in the quantity of ascorbate-deficient guinea pig FM0 compared to ascorbate-supplemented 
was indicated by a marked reduction in total FM0 activity recovered from blue agarose chromatography 
and reduced protein staining intensity with SDS-PAGE at 56,000 daltons. 
The flavin-containing monooxygenase (FMO; EC 
1.14.13.8) is a flavoprotein present in most mam- 
malian species, which catalyzes the oxidation of a 
large variety of nitrogen- and sulfur-containing drugs 
and environmental chemicals [l-4]. Oxidation of the 
nucleophilic center for the majority of compounds 
leads to less toxic derivatives but, depending on the 
nature of the compound, oxidation may result in the 
formation of reactive intermediates which could have 
toxicological consequences [5,6]. The enzyme has 
been purified and characterized from the hepatic 
tissue of pig, rat and mouse and from rabbit lung 
[7-91. Species and tissue differences in catalytic and 
immunological properties have been reported, sug- 
gesting that the FM0 can exist as more than a single 
form [8,9]. 
The activity of FM0 appears to be under 
nutritional and hormonal control [lO-121. Recent 
studies have demonstrated that the FM0 is jeop- 
ardized in ascorbic acid deficiency [13]. To date it 
has been shown that guinea pigs maintained on an 
ascorbic-acid-deficient diet have a significant 
reduction (45%) in the N-oxidation of dimethyl- 
aniline, an FM0 substrate [13]. Since the quantity 
of cytochrome P-450 is reduced markedly in ascorbic 
acid deficiency [14], it was also demonstrated that 
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the effect of ascorbic acid deficiency on the FM0 is 
unrelated to the previously established reduction in 
the cytochrome P-450 electron transport system. 
The present study investigated the biochemical 
mechanism by which ascorbic acid deficiency causes 
the reduction in the flavin-containing monooxy- 
genase. Several important properties of FM0 iso- 
lated from ascorbic-acid-deficient guinea pigs 
compared to ascorbic-acid-supplemented animals 
are described in this study. These properties include 
differences in purification characteristics, effects on 
the enzyme-cofactor (FAD) relationship, and kinetic 
properties of the FMO. 
MATERIALS AND METHODS 
Materials. Sodium ascorbate, NADP+, NADPH, 
Triton X-100, DEAE-cellulose, and blue-Zagarose 
type 3000-CL were purchased from the Sigma 
Chemical Co. (St. Louis, MO). Dimethylaniline was 
purchased from the Fisher Scientific Co. (Fair Lawn, 
NJ). Thiobenzamide and n-octylamine were pur- 
chased from the Aldrich Chemical Co. (Milwaukee, 
W. p-Nitroanisole, N,N,N’,N’-tetrarnethyl- 
ethylenediamine and p-nitrophenol were purchased 
from Eastman Kodak (Rochester, NY). Acrylamide 
and N,N’-methylene bisacrylamide were purchased 
from International Biotechnologies, Inc. (New 
Haven, CT). 2’,5’-ADP Sepharose was purchased 
from P-L Biochemicals (Milwaukee, WI). Sodium 
dodecyl sulfate was purchased from BDH Chemicals 
Ltd. (Poole, England). Ascorbic-acid-deficient diet 
(guinea pig pelleted) was obtained from Nutritional 
Biochemicals (Cleveland, OH). Male Hartley guinea 
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pigs were purchased from the Michigan Department 
of Public Health (Lansing, MI). All chemicals used 
were of reagent grade or better. 
Guinea pigs. Guinea pigs were pair-fed, and the 
microsomal pellet was prepared as previously 
described [ 131. 
Purification of jlavin-containing monooxygenase. 
The FM0 was purified by the modification of pre- 
viously established procedures [8,15]. The micro- 
somal pellet was adjusted to 15-20mg protein/ml 
with 10 mM potassium phosphate, pH7.8, 1 mM 
EDTA, 20% glycerol (buffer A). Solubilization of 
the FM0 was achieved by the addition of an equal 
volume of buffer A containing 1% Triton X-100. 
After stirring for 25 min at 4”, the mixture was centri- 
fuged for 1.5 hr at 100,000 g to ensure solubilization. 
Approximately 9 ml of solubilized microsomes 
(8 mg/ml) was applied directly to a column of 
DEAE-cellulose (0.9 cm x 19 cm). The FM0 was 
eluted with the equilibration buffer B (buffer A 
containing 0.2% Triton X-100). The FM0 was not 
retained on this column. The eluate containing FM0 
enzyme was loaded onto a column of blue 2-agarose 
type 3OOO-CL (0.9 cm X 14 cm) which was pre-equi- 
librated with buffer B (buffer A containing 0.2% 
T&on). Approximately 9 ml of DEAE-purified 
FM0 (2.5 mg/ml) was applied to the blue agarose 
column which had a flow rate of 6 ml/hr. The column 
was washed with 10 column volumes of buffer B, 
and FM0 activity was eluted with a linear gradient 
(20 column volumes) of &l M KC1 in buffer B. 
Fractions containing FM0 activity were pooled and 
dialyzed against buffer B. The dialyzed pooled frac- 
tion (14ml) was applied to a column of 2’,5’-ADP 
Sepharose (0.5 cm x 8 cm) which was pre-equi- 
librated with buffer C (buffer A containing 0.5% 
Triton X-100). The column had a flow rate of 6 ml/ 
hr. The column was washed with 10 column volumes 
of 5 mM 2’-AMP in buffer C, and FM0 activity was 
eluted with 0.1 mM NADPH in buffer C (10 column 
volumes). The flavin-containing monooxygenase was 
purified 50-fold. The FM0 was dialyzed against 
buffer A and concentrated prior to SDS-PAGE. 
Since the ascorbic-acid-deficient guinea pig FM0 
was highly labile following the 2’,5’-ADP Sepharose 
column chromatography, all kinetic experiments 
were conducted with FM0 eluted from the blue 
agarose column. 
most 25% of the FM0 enzyme reaction. The reaction 
was carried out at 37” and initiated by the addition 
of dimethylaniline. Since FAD in the presence of 
dimethylaniline and the absence of FM0 results in 
the oxidation of NADPH, this non-enzymatic oxi- 
dation of NADPH was subtracted from the overall 
rate observed in the presence of enzyme. The reac- 
tion was linear and proportional to enzyme con- 
centration. The reaction rates were determined using 
a molar absorptivity of 6220 M-l cm-’ for NADPH. 
The FAD-activated and non-FAD-activated activity 
measured by NADPH disappearance was equivalent 
to the rate of appearance of oxidized product, 
dimethylaniline N-oxide. Dimethylaniline N-oxide 
product was determined by the method of Ziegler 
and Pettit [17] as modified previously [13]. 
Thiobenzamide S-oxide. Thiobenzamide S-oxide 
product was determined by the method of Cashman 
and Hanzlik [18] as modified [13]. 
p-Nitroanisole 0-demethylation. p-Nitroanisole O- 
demethylation was determined by the modified 
method of Zannoni [13,19]. 
Protein determination. Protein was determined by 
the method of Lowry et al. [20], with bovine serum 
albumin as the standard. Protein samples were dia- 
lyzed to remove the Triton X-100 when necessary. 
Sodium dodecyl sulfate gel electrophoresis. Poly- 
acrylamide slab gel electrophoresis in the presence of 
sodium dodecyl sulfate (SDS) was performed using a 
discontinuous buffer system described by Laemmli 
[21]. Protein samples (0.02ml containing 0.05 to 
0.3 mg/ml) that had been treated previously with 1% 
SDS and 1% mercaptoethanol at 100” for 2 min were 
applied to a 7.5% acrylamide gel and subjected to 
electrophoresis in a vertical slab electrophoresis 
assembly (Hoefer Scientific Instruments). Elec- 
trophoresis was carried out at 25 mA/gel during sep- 
aration. The gels were stained in Coomassie blue in 
H,G-2-propanol-acetic acid (65 : 25 : 10) for at least 
3 hr and destained at room temperature in the same 
solvent until the background was cleared. The stand- 
ard proteins used as molecular weight markers were: 
phosphorylase B, 92,500; bovine serum albumin, 
66,200; ovalbumin, 45,000; carbonic anhydrase, 
31,000; and soybean trypsin inhibitor, 21,500. 
RESULTS 
Assay of flavin-containing monooxygenase. The The flavin-containing monooxygenase was par- 
metabolism of dimethylaniline can be measured by tially purified from ascorbic-acid-supplemented and 
following the oxidation of NADPH at 340 nm [16]. -deficient guinea pig livers by DEAE-cellulose and 
The rate of NADPH disappearance was determined blue-Zagarose 3000~CL chromatography. The asc- 
using an Aminco DW-2 UV/vis spectrophotometer orbic-acid-supplemented guinea pig FM0 eluted 
in the split-beam mode at 340nm. The standard from the blue agarose column in two regions: an 
assay mixture contained 25 mM sodium phosphate, FAD-activated region at 0.36 M KC1 (region A) and 
100 mM glycine, pH 8.4,0.4 mM EDTA, 0.08% Tri- a non-FAD-activated region at 0.51 M KC1 (region 
ton, 3 mM octylamine, 0.125 mM NADPH, and an B) (Fig. 1). Region A enzyme required the addition 
appropriate amount of enzyme in both the control of exogenous FAD for optimal activity. However, 
and experimental cuvettes. Dimethylaniline (2 mM) FM0 activity could be detected in the A region 
was added to the experimental cuvette only. FAD- without the addition of exogenous FAD. This 
activated activity was determined by the addition of enzyme activity may have been derived from the B 
0.05mM FAD to the incubation media. NADPH region. The addition of exogenous FAD to region B 
and enzyme were included in both the experimental had no effect. Since this region had high activity 
and control cuvettes to account for the substrate- already, this is not surprising. The ascorbic-acid- 
independent NADPH disappearance. In general, the deficient guinea pig FM0 eluted from the blue aga- 
non-dimethylaniline NADPH oxidation was at the rose column in two distinct fractions (Fig. 2). There 
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FAD-activated FM0 activity (region B) with 
enzyme purified from ascorbic-acid-deficient animals 
compared to ascorbic-acid-supplemented ones (Figs. 
1 and 2). 
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Fig. 1. Elution profile of ascorbic-acid-supplemented 
guinea pig hepatic flavin-containing monooxygenase by 
blue-2-agarose 3000-CL column chromatography. FM0 
was ourified from solubilized microsomes as described in 
Matdrials and Methods. FM0 activity was eluted with a O- 
1 M KC1 gradient and monitored by NADPH oxidation 
as described in Materials and Methods. The non-FAD- 
activated fraction was determined without the addition of 
exogenous FAD. Region A: fractions 46-70; region B: 
fractions 75-110. Key: (0) FAD-activated fraction; and 
(0) non-FAD-activated fraction. 
was no detectable activity in the A region without 
the addition of exogenous FAD. This is in contrast 
to the equivalent fraction obtained from the ascorbic- 
acid-supplemented preparation (Fig. 1). Further- 
more, there was a marked reduction in the non- 
Table 1 summarizes the purification and recovery 
of FM0 isolated from ascorbic-acid-deficient and 
-supplemented guinea pig hepatic microsomal prep- 
arations. In the original microsomal preparation, 
there was a 4-fold reduction in the ascorbic-acid- 
deficient guinea pig microsomal FM0 specific 
activity compared to the ascorbic-acid-supplemented 
guinea pigs (11.7nmol~min-1~mg-1 vs 2.8). The 
quantitative reduction in FM0 activity with ascorbic 
acid deficiency was maintained during purification 
(86.7 nmol~min-l-mg-l vs 17). Recovery of ascorbic- 
acid-supplemented guinea pig FM0 from the blue 
agarose column was 35% of the initial microsomal 
activity. Only 5% of the total microsomal activity 
was FAD-activated enzyme (Table 1). In contrast, 
22% of the microsomal ascorbic-acid-deficient FM0 
was recovered from the blue agarose column and 
15% of this activity was FAD-activated activity, 3- 
fold more than was found with the ascorbic-acid- 
supplemented guinea pig FMO. In spite of this 
substantial FAD activation on ascorbic-acid-defi- 
cient enzyme, the total quantity of recoverable 
enzyme did not approach enzyme prepared from 
ascorbic-acid-supplemented animals (45 nmol/min 
vs 274). 
Ascorbic-acid-supplemented and -deficient guinea 
pig liver FM0 which eluted from the blue agarose 
column in the B region was further purified by a 
2’,5’-ADP Sepharose column and subjected to SDS- 
PAGE (Fig. 3). Previous studies have indicated that 
hog liver FM0 has a molecular weight of 56,000 
when subjected to SDS-PAGE [22]. The ascorbic- 
acid-deficient guinea pig FM0 exhibited a distinct 
decrease in protein banding in the 56,000 dalton 
region compared to the ascorbic-acid-supplemented 
enzyme. Furthermore, this quantitative decrease was 
also observed when FM0 partially purified by 
DEAE-cellulose and blue-Zagarose 3000-CL was 
subjected to SDS-PAGE. 
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Fig. 2. Elution profile of ascorbic-acid-deficient guinea 
pig hepatic flavin-containing monooxygenase by blue-Z 
agarose 3000-CL column chromatography. FM0 was puri- 
fied from solubilized microsomes as described in Materials 
and Methods. Flavin-containing monooxygenase activity 
was eluted with a O-1 M KC1 gradient and monitored by 
NADPH oxidation as described in Materials and Methods. 
The non-FAD-activated fraction was determined without 
the addition of exoeenous FAD. The FM0 activitv was 
non-detectable with&t the addition of exogenous FAD in 
fractions 55-80. The limit of detection of the assay was 
0.47 nmol.min-‘m-‘. Region A: fractions 5S-80; region 
B: fractions SO-105 Key: (0) FAD-activated fraction; and 
(0) non-FAD-activated fraction. 
In addition to the N-oxidation of dimethylaniline, 
the metabolism of thiobenzamide, a sulfur FM0 
substrate, was also activated by FAD in the presence 
of FAD-activated enzyme. Also, the activation by 
FAD appeared to be specific for FAD in that the 
addition of ascorbic acid (0.025 to 1.0 mM) did not 
have an effect on the enzyme. There was no signifi- 
cant difference in the apparent affinity constants 
(K,) of the FAD-activated and non-FAD-activated 
FM0 from both ascorbic-acid-supplemented and 
-deficient guinea pig for dimethylaniline and 
NADPH (Table 2). The K,,, of dimethylaniline was 
in the order of 3 x 10e4 M for all four enzyme frac- 
tions. In addition, the V,,,,, for dimethylaniline with 
FAD-activated FM0 from both the ascorbic-acid- 
supplemented and -deficient animals was 1 .O nmol/ 
min and with non-FAD-activated enzyme was 3.7 
for the ascorbic-acid-supplemented animals com- 
pared to 1.3 for the ascorbic-acid-deficient animals. 
The K,,, of NADPH for the FAD-activated FM0 was 
2.0 x 10m5 M and 5.0 X low5 M for the non-FAD- 
activated FM0 prepared from ascorbic-acid-sup- 
plemented guinea pigs. Similarly, the Km of NADPH 
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Table 1. purification of flavin-containing monooxygenase with DEAE-cellulose and blue agatose column chromatography 
Fraction Volume Protein Specific activity Total activity Recovery 
(ml) (mg/ml) (nmol/min/mg) (nmol/min) W) 
Ascorbic acid supplemented 
100,000 g microsome 
Blue agarose 
(FAD-activated plus non-FAD-activated) 
FAD-activated 
Non-FAD-activated 
Ascorbic acid deficient 
100,000 g microsome 
Blue agarose 
(FAD-activated plus non-FAD-activated) 
FAD-activated 
Non-FAD-activated 
4.5 15.20 11.7 790 loo 
40.0 0.08 86.7 274 35 
15.0 0.07 39.2 40 5 
25.0 0.09 110.0 234 30 
4.2 18.00 2.8 208 100 
40.0 0.07 17.0 45 22 
20.0 0.05 28.3 30 15 
20.0 0.08 9.4 15 7 
Flavin-containing monooxygenase activity was monitored by NADPH oxidation as described in Materials and Methods. 
The average hepatic level of ascorbic acid in supplemented animals was 29 ? 13 mg/lOO g wet liver weight and 1.8 f 1.3 mg 
in deficient animals. 
for the FAD-activated FM0 was 2.8 x 10e5 M and 
7.3 x lo-5 M for the non-FAD-activated FM0 pre- 
pared from ascorbic-acid-deficient guinea pigs. 
The K,,, for FAD with purified enzyme preparations 
Fig. 3. SDS electrophoresis of partially purified hepatic 
FM0 prepared from ascorbic-acid-supplemented and 
-deficient guinea pigs. Electrophoresis was performed in 
7.5% polyacrylamide gel as described in Materials and 
Methods. The direction of migration was from top to 
bottom. Protein was loaded as follows: lane 1, standards, 
6 pg; lane 2, ascorbic-acid-supplemented guinea pig puri- 
fied (50-fold) Fh40, 2.5 pgg; lane 3, ascorbic-acid-deficient 
guinea pig purified (50-fold) m0, 2.5 pg. The average 
hepatic level of ascorbic acid in supplemented animals was 
29 ‘. 13 mg/lOO g wet liver weight and 1.8 5 1.3 mg in the 
deficient animals. The protein standards were: phospho- 
rylase B, 92,500; bovine serum albumin, 66,200; ovalbu- 
min, 45,000; carbonic anhydrase, 31,000; and soybean 
The non-FAD-activated enzyme was found to 
demonstrate a time-dependent nonlinearity (Fig. 4). 
Ascorbic-acid-deficient guinea pig FM0 had an 
initial reaction rate which was linear for approxi- 
mately 100 set in the presence of 2 mM dimethyl- 
aniline, the usual substrate concentration. By 400 set 
only 10% of this initial rate was maintained. In 
contrast, the non-FAD-activated FM0 from 
ascorbic-acid-supplemented guinea pigs still had 
60% of its initial rate after 4OOsec. The inhibition 
of metabolism was found to be dependent on the 
concentration of dimethylaniline (Table 3). As the 
concentration of dimethylaniline was reduced from 
2 to 0.08 mM, the degree of inhibition was reduced 
from 90 to 50% for the ascorbic-acid-deficient guinea 
pig FM0 and from 40 to 10% for the ascorbic-acid- 
supplemented guinea pig FMO. The nonlinearity 
could not be prevented by EDTA, 0.4 mM; benzo- 
ate, 50 mM, 12.5 mM; dimethyl sulfoxide, 50 mM; 
ascorbate, 1 mM, 0.2 mM; or catalase. 0.4 pg/14 pg 
enzyme protein. In addition to the enhanced sen- 
sitivity to time-dependent nonlinearity with purified 
enzyme from ascorbic-acid-deficient guinea pigs, the 
enzyme was also very labile upon freezing. Purified 
enzyme prepared from ascorbic-acid-supplemented 
guinea pigs was stable for 4 weeks at -20%) whereas 
the activity of the enzyme prepared from ascorbic- 
acid-deficient animals was non-detectable. 
DISCUSSION 
Our previous study demonstrated an in vivo 
requirement for ascorbic acid to maintain the FM0 
[13]. The present study deals with the biochemical 
basis for the participation of ascorbic acid with the 
FMO. Evidence is presented which indicates that 
qualitative and quantitative differences occur 
between FM0 isolated from ascorbic-acid-deficient 
and -supplemented guinea pig livers. 
trypsin inhibitor, 21,500. The reduction in hepatic FM0 activity with ascor- 
from ascorbic-acid-deficient guinea pigs and from 
ascorbic-acid-supplemented animals was in the order 
of 6 x 1O-7 M. 
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Table 2. Apparent affinity constants for flak-containing monooxygenase 
Fraction K, (M) 
Dimethylaniline NADPH FAD 
Ascorbic acid supplemented 
FAD-activated fraction 
Non-FAD-activated fraction 
Ascorbic acid deficient 
FAD-activated fraction 
Non-FAD-activated fraction 
2.1 x 1o-4 2.0 x 10-s 5.0 x lo-’ 
3.2 x 1O-4 5.0 x 10-S 
3.4 x 10-4 2.8 x 1O-s 6.7 x 1O-7 
3.3 x 10-4 7.3 x 10-S 
Partially purified Ravin-containing monooxygenase activity was monitored by NADPH oxi- 
dation as described in Materials and Methods. Kinetic data were obtained by measuring FM0 
activity using at least five different concentrations of dimethylanihne, NADPH, or FAD from 
0.2 to 5 times the K,,, value. The non-FAD-activated fraction was determined without the addition 
of exogenous FAD, and exogenous FAD had no effect on the activity determined in this fraction. 
Each value represents the mean of at least two experiments. 
bit acid deficiency could result from a qualitative 
alteration in the enzyme which impedes the oxidation 
mechanism by which substrates are metabolized. 
Ascorbic acid deficiency could be disrupting this 
process by altering the binding of NADPH, oxygen, 
FAD or, for that matter, the xenobiotic itself. 
Another possibility is that ascorbic acid deficiency 
causes an alteration in the active enzyme complex 
which interferes with the electron flow through the 
transport cycle. In view of the fact that there is no 
alteration in the affinity (K,) for dimethylaniline or 
NADPH with purified ascorbic-acid-deficient guinea 













Fig. 4. Time-dependent nonlinearity of non-FAD-activated 
FM0 activity with 2 mM dimethylaniline. FM0 activity 
was monitored by following the rate of NADPH oxidation 
at 340nm as described in Materials and Methods. The 
initial rate of metabolism was adjusted to be the same for 
the ascorbic acid supplemented and deficient guinea pigs 
by varying the amount of enzyme in the incubation media. 
The same degree of time-dependent nonlinearity was 
observed when the incubation media contained the same 
protein concentration and the same concentration of Triton 
X-100 for both the ascorbic-acid-supplemented and 
-deficient guinea pigs. Key: (0) ascorbic-acid- 
supplemented guinea pig FMO; and (x) ascorbic-acid- 
deficient guinea pig FMO. 
ciency is not causing a reduction in FM0 activity by 
altering the affinity for substrate of NADPH. 
FAD-activated FM0 was recovered from both the 
ascorbic-acid-supplemented and -deficient guinea 
pigs. This enzyme may represent a form of FM0 
which binds FAD with a lower affinity. Since the 
FAD-activated FM0 from both the ascorbic-acid- 
supplemented and -deficient guinea igs had an FAD 
affinity (K,) in the order of 6 x lo- Y M, this hypoth- 
esis cannot be confirmed at this time. Purified 
ascorbic-acid-deficient guinea pig FM0 is more 
dependent than the ascorbic-acid-supplemented 
guinea pig on the addition of exogenous FAD for 
optimal activity. Three-fold more of the ascorbic- 







Metabolism rate after 400 set 
Initial rate of metabolism 








Non-FAD-activated flavin-containing monooxygenase 
activity was monitored by NADPH oxidation as described 
in Materials and Methods. The concentration of dimethyl- 
aniline used in each assay is indicated in the table. The 
initial rate of metabolism was adjusted to be the same for 
the ascorbic-acid-supplemented and -deficient guinea pigs 
by varying the amount of enzyme in the incubation media. 
The same degree of time-dependent nonlinearity was 
observed when the incubation media contained the same 
protein concentration and the same concentration of Triton 
X-100 for both the ascorbic-acid-supplemented and -defi- 
cient guinea pigs. Each value represents the mean of two 
experiments. 
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acid-deficient guinea pig FMO, recovered from the 
blue agarose column, required exogenous FAD than 
the ascorbic-acid-supplemented enzyme. Ascorbic 
acid deficiency may be causing an enhancement in 
the FAD dependency by either altering the associ- 
ation between the apoenzyme and FAD or modifying 
the enzyme in such a manner that the flow of elec- 
trons necessary for substrate oxidation is impeded. 
Since there was no difference in the affinity Km 
for FAD with FAD-activated ascorbic-acid-deficient 
guinea pig FM0 compared to FAD-activated 
ascorbic-acid-supplemented animals, ascorbate 
deficiency does not appear to alter the binding of 
FAD to the apoenzyme. 
In keeping with this, the possibility that ascorbic 
acid may have a role in the transfer of electrons is 
suggested by the electron donating capacity of this 
vitamin 1231. However, the addition of ascorbic acid 
to the incubation media of FAD-activated FM0 did 
not result in an activation of the enzyme. One cannot 
discount the possibility, though, that upon puri- 
fication the sterochemical relationship between vit- 
amin, cofactor and apoenzyme may be such that the 
vitamin is incapable of operating effectively under 
these ipl vitro conditions. 
Ascorbic acid deficiency could also be indirectly 
affecting the flow of electrons. The addition of 
exogenous FAD to the microsomal preparation had 
no effect on the activity of the FMO. Therefore, the 
microsomal milieu appears to prevent the alteration 
of the enzyme from occurring, but once the enzyme 
is solu~lized it is sensitive to this FAD dependency. 
The potential importance of the microsomal environ- 
ment to electron transfer has been demonstrated 
by the cytochrome P-450 electron transport system 
which is dependent on the presence of phospha- 
tidylcholine for electron transfer 1241. In addition, it 
has been suggested that the active FM0 complex 
exists as aggregates of several monome~c units and 
that the active enzyme is an octamer which is in 
equilibrium with tetrameric forms [22]. Therefore, 
possibly in ascorbic acid deficiency the membrane 
environment is altered in such a manner that the 
aggregation of the enzyme needed for product for- 
mation is inhibited. The addition of exogenous FAD 
could enable the enzyme to overcome this uncoup- 
ling of the oxidative mechanism. 
The enhanced sensitivity of purified ascorbic acid- 
deficient guinea pig FM0 to time-dependent non- 
linearity supports the theory that ascorbic acid defi- 
ciency results in an impairment of the oxidative 
mechanism. The nonlinearity was found to follow an 
initial lag period and was dependent on the substrate 
concentration. The degree of nor&near&y decreased 
as the concentration of substrate was decreased 
below the Km. These two facts suggest that the non- 
linearity may be related to either a product formed 
or the turnover of the enzyme. The time-dependent 
nonlinearity does not appear to be related to the 
formation of a secondary reactive oxygen product, 
since the nonlinearity could not be prevented by 
ascorbic acid, EDTA, benzoate, dimethyl sulfoxide 
or catalase. The second possibility, that the time- 
dependent nonlinearity is related to the enzyme turn- 
over, supports the theory that ascorbic-acid-deficient 
guinea pig FM0 may be altered in such a manner 
that the process of electron transfer is vulnerable. 
Although the enzyme is initially able to oxidize the 
substrate, the stress of electron transfer may result 
in a progressive decay of this process. Additional 
evidence for the instability of the active complex of 
the ascorbic-acid-deficient guinea pig FM0 is the 
high lability that occurs upon freezing purified 
ascorbic-acid-deficient guinea pig FM0 as compared 
to ascorbic-acid-supplemented fractions. 
The results of this study also suggest the possibility 
that ascorbic acid deficiency results in a quantitative 
reduction in the FMO. In the original microsomal 
preparation, there was a 4-fold reduction in the 
specific activity of the ascorbic-acid-deficient guinea 
pig microsomal FM0 compared to the ascorbic-acid- 
supplemented animals. Following purification, even 
with FAD activation, this reduction in activity was 
ma~tained. The decrease in FM0 specific activity 
could be related to either the presence of inactive 
enzyme or a quantitative alteration in the ascorbic- 
acid-deficient enzyme. A quantitative reduction in 
ascorbic-acid-deficient guinea pig FM0 is indicated 
by a consistent decrease in protein staining intensity 
at the 56,000 molecular weight band with both par- 
tially purified and purified enzyme compared to 
a~orbic-acid-supplemented FMO. Although the 
decrease observed in the relative staining intensity 
may reflect changes in the quantity of FMO, 
immunoelectrophorectic techniques would be help- 
ful to substantiate and confirm a quantitative 
decrease of the FM0 under ascorbic acid deficiency. 
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